Berwyn Clarke

Berwyn Clarke

Ordförande på
Novai Ltd.
70 år
Health Technology
Consumer Services
Commercial Services

Profil

Berwyn Ewart Clarke was the founder of Lab 21 Ltd. (founded in 2005) and held the title of Director, Chief Scientific & Development Officer from 2012 to 2013.
Dr. Clarke is also the founder of Oneida TheraDiagnostics Ltd. Dr. Clarke's current job(s) include being the Chairman of Iceni Diagnostics Ltd., Co-Chairman of Novai Ltd., and Director of PBD Biotech Ltd. (since 2014).
Dr. Clarke's former job(s) include being the Interim Chief Executive Officer of Replizyme Ltd., Director of Glyconics Ltd. (from 2013 to 2023), and holding positions at Wellcome Plc and Virco Group.
Dr. Clarke obtained a doctorate degree from Imperial College London and an undergraduate degree from the University of Kent.

Aktiva positioner av Berwyn Clarke

FöretagPositionStart
Direktör/Styrelseledamot 2014-02-17
Ordförande -
Ordförande -

Tidigare kända positioner av Berwyn Clarke

FöretagPositionSlut
Direktör/Styrelseledamot 2023-08-29
Grundare 2013-01-31
Replizyme Ltd.
President -
Företagsledare/Principal -
Företagsledare/Principal -
Se detaljerna i Berwyn Clarkes erfarenhet

Berwyn Clarkes utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

13

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Consumer Services

Commercial Services

Health Services

Health Services

Oneida TheraDiagnostics Ltd.

Replizyme Ltd.

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Börsen
  2. Insiders
  3. Berwyn Clarke